Murphy & Mullick Capital Management Corp Teva Pharmaceutical Industries LTD Transaction History
Murphy & Mullick Capital Management Corp
- $109 Billion
- Q4 2024
A detailed history of Murphy & Mullick Capital Management Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 208 shares of TEVA stock, worth $3,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208Holding current value
$3,450% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
647Shares Held
585MCall Options Held
18.8MPut Options Held
7.13M-
Black Rock Inc. New York, NY43MShares$713 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$646 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$601 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$478 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$451 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...